Project Grant HT94252411070
Award Date
11/1/24
Completion Date
10/31/27
Dollars Obligated
$1.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43210, USA
Similar Awards
The federal Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a $1,126,946 research initiative aimed at cardiovascular risk profiling of deployment-related respiratory diseases. The grant was awarded on November 1, 2024 to the Veterans Bio-Medical Research Institute, Inc., a non-profit research organization located in East Orange, New Jersey. This translational research project investigates innovative...
The Ohio State University will receive $1,181,604 under a four-year Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The funding will support research into developing new methods to access extracellular vesicle MDM2 DNA cargo as a potential biomarker for liposarcoma. The grant aims to transform health care for service members and the public through innovative biomedical research investigating medical solutions for...
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $551,250.00 to The Ohio State University to support research on PPP2R1B IN DEDIFFERENTIATED LIPOSARCOMA. The project will be performed in Columbus, OH and run from Sep 30, 2023 through Sep 29, 2026. The Ohio State University has a history of conducting biomedical research and providing clinical trial coordination services to federal agencies like the National...
This $1,574,999.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by The Ohio State University to investigate SLIT2 as a novel approach for targeting metastatic breast cancer. The award period runs from June 15, 2025 to June 14, 2028. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical solutions to critical health...
The Defense Health Agency awarded a $512,751.00 Project Grant to The Ohio State University for the period from July 1, 2023 to June 30, 2026. The grant was provided under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for Service Members and the American public through innovative and impactful research, and to investigate medical solutions for the battlefield. The grant funds will...
This federal Project Grant award of $1,317,976.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at The Ohio State University to target the RAL G proteins for the treatment of triple-negative breast cancer. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical investigations in cancer treatment. The award has a performance period from...
The Ohio State University received a $248,237 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award will fund a 3-year project from July 1, 2023 to June 30, 2026 to research and address traumatic brain injuries among law enforcement officers. No additional details about specific products or services to be delivered under this award were provided. The Military Medical Research and Development program supports basic,...
This federal Project Grant award of $267,311 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a randomized clinical trial utilizing crisis response planning for suicide prevention in military personnel with traumatic brain injury. The award was made to The Ohio State University, which will serve as the prime recipient, with a performance period from August 1, 2024 to July 31, 2027. The project aims to...
The Ohio State University received a $156,000 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program. The two-year award beginning in June 2021 will support research on Fatty Acid Binding Protein-5 as a novel therapeutic target against aggressive lung cancer. Through this funding, The Ohio State University researchers will investigate medical solutions for lung cancer, advancing the Military Medical Research...
The federal Project Grant award "PRESERVING VISION AFTER NEUROTRAUMA (PREVANT)" was provided by the Defense Health Agency under CFDA Program 12.420 - Military Medical Research and Development. The $1,479,970.00 award to The Ohio State University, with a performance period from July 15, 2025 to July 14, 2029, will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research will focus on innovative...